{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:35:12Z","timestamp":1767861312653,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:00:00Z","timestamp":1433289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DHHS CDC","award":["200-2000-10065"],"award-info":[{"award-number":["200-2000-10065"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.091","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T07:55:42Z","timestamp":1434182142000},"page":"3709-3716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans"],"prefix":"10.1016","volume":"33","author":[{"given":"Jarad M.","family":"Schiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Niemuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Sabourin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.091_bib0120","unstructured":"Anthrax Vaccine Adsorbed United States patent US 3208909. September 28, 1965."},{"key":"10.1016\/j.vaccine.2015.05.091_bib0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future","volume":"9","author":"Turnbull","year":"1991","journal-title":"Vaccine"},{"issue":"RR06","key":"10.1016\/j.vaccine.2015.05.091_bib0130","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Centers for Disease Control and Prevention (CDC)","volume":"59","author":"Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0135","series-title":"Bacillus anthracis and anthrax","first-page":"269","article-title":"Bacillus anthracis and Anthrax","author":"Saile","year":"2010"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0145","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0150","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1016\/j.vaccine.2013.08.086","article-title":"Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity","volume":"31","author":"Pittman","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0264-410X(00)00174-2","article-title":"Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans","volume":"19","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0160","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2013.10.039","article-title":"Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial","volume":"32","author":"Wright","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0165","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/CVI.00324-12","article-title":"A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques","volume":"19","author":"Quinn","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0170","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/CVI.00469-14","article-title":"Comprehensive analysis and selection of anthrax vaccine immune correlates of protection in rhesus macaques","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nbt1007-1084","article-title":"The FDA animal efficacy rule and biodefense","volume":"25","author":"Gronvall","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0180","doi-asserted-by":"crossref","first-page":"151ra126","DOI":"10.1126\/scitranslmed.3004073","article-title":"Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge","volume":"4","author":"Fay","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0185","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2008.04.016","article-title":"Prediction of pertussis vaccine efficacy using a correlates of protection model","volume":"26","author":"Kohberger","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0190","series-title":"An introduction to the Bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2011.12.002","article-title":"Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-Pa IgG","volume":"376","author":"Semenova","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0205","first-page":"6","article-title":"An epidemic of inhalation anthrax: the first in the twentieth century","volume":"72","author":"Brachman","year":"1960","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0210","first-page":"2","article-title":"Bacillus anthracis aerosol in goat hair processing mills","volume":"72","author":"Dahlgren","year":"1960","journal-title":"Am J Hyg"},{"issue":"8","key":"10.1016\/j.vaccine.2015.05.091_bib0215","doi-asserted-by":"crossref","first-page":"1003555","DOI":"10.1371\/journal.ppat.1003555","article-title":"Quantitative models of the dose response and time course of inhalational anthrax in humans","volume":"9","author":"Toth","year":"2013","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/IDR.S10339","article-title":"Review of oral cholera vaccines: efficacy in young children","volume":"4","author":"Masuet Aumatell","year":"2011","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/hv.26319","article-title":"Human Rotavirus Vaccine (Rix4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China","volume":"10","author":"Li","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.05.091_bib0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/INF.0b013e31820a8b3c","article-title":"Active Bacterial Core surveillance (ABCs) Team and MeningNet Surveillance Partners. Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine","volume":"30","author":"MacNeil","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:42:25Z","timestamp":1565419345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15007653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":23,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15007653"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}